Paula M Trief1, Dongyuan Xing2, Nicole C Foster2, David M Maahs3, Julie M Kittelsrud4, Beth A Olson5, Laura A Young6, Anne L Peters7, Richard M Bergenstal5, Kellee M Miller8, Roy W Beck2, Ruth S Weinstock1. 1. Endocrinology, Diabetes, and Metabolism, Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY. 2. Jaeb Center for Health Research, Tampa, FL. 3. Barbara Davis Center for Childhood Diabetes, Aurora, CO. 4. Avera McKennan Hospital & University Health Center, Sioux Falls, SD. 5. Park Nicollet International Diabetes Center, Minneapolis, MN. 6. Diabetes Center for Research, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC. 7. Keck School of Medicine of USC, Los Angeles, CA. 8. Jaeb Center for Health Research, Tampa, FL t1dstats@jaeb.org.
Abstract
OBJECTIVE: Little is known about the frequency of depression in adults with type 1 diabetes (T1D) or its relationship to diabetes outcomes. The T1D Exchange clinic registry allowed us to explore depression in a large, heterogeneous sample. RESEARCH DESIGN AND METHODS: Participants ≥18 years old (N = 6,172; median age 34 years; median diabetes duration 16 years; 55% female; and 89% non-Hispanic white) completed the eight-item Patient Health Questionnaire (PHQ-8), a validated, reliable measure of current depression. Probable major depression was defined in four ways: PHQ-8 ≥10, PHQ-8 ≥12, per diagnostic algorithm, and as a continuous variable. Characteristics and clinical outcomes of those with and without depression were compared using logistic and linear regression models. RESULTS: A total of 4.6-10.3% of participants were classified as probable major depression depending on how defined. Participants classified as depressed were more likely female, nonwhite race/ethnicity, to have a lower household income and lower education level, to exercise less often, to miss insulin doses, and to have one or more complications (neuropathy, nephropathy, treatment for retinopathy, or cardiovascular/cerebrovascular disease) (all P < 0.01). HbA1c was higher in the depressed versus not depressed groups (8.4 ± 1.7% [68 ± 8.6 mmol/mol] vs. 7.8 ± 1.4% [62 ± 15.3 mmol/mol]; P < 0.001). Occurrence of one or more diabetic ketoacidosis events (11 vs. 4%; P < 0.001) and one or more severe hypoglycemic events (18 vs. 9%; P < 0.001) in the past 3 months was higher among depressed participants. CONCLUSIONS: In the T1D Exchange clinic registry, adults with probable major depression have worse clinical outcomes than those not depressed. Whether identification and treatment of depression improves diabetes outcomes requires study. Depression is common in T1D, and better identification and treatment of this comorbid condition is needed.
OBJECTIVE: Little is known about the frequency of depression in adults with type 1 diabetes (T1D) or its relationship to diabetes outcomes. The T1D Exchange clinic registry allowed us to explore depression in a large, heterogeneous sample. RESEARCH DESIGN AND METHODS: Participants ≥18 years old (N = 6,172; median age 34 years; median diabetes duration 16 years; 55% female; and 89% non-Hispanic white) completed the eight-item Patient Health Questionnaire (PHQ-8), a validated, reliable measure of current depression. Probable major depression was defined in four ways: PHQ-8 ≥10, PHQ-8 ≥12, per diagnostic algorithm, and as a continuous variable. Characteristics and clinical outcomes of those with and without depression were compared using logistic and linear regression models. RESULTS: A total of 4.6-10.3% of participants were classified as probable major depression depending on how defined. Participants classified as depressed were more likely female, nonwhite race/ethnicity, to have a lower household income and lower education level, to exercise less often, to miss insulin doses, and to have one or more complications (neuropathy, nephropathy, treatment for retinopathy, or cardiovascular/cerebrovascular disease) (all P < 0.01). HbA1c was higher in the depressed versus not depressed groups (8.4 ± 1.7% [68 ± 8.6 mmol/mol] vs. 7.8 ± 1.4% [62 ± 15.3 mmol/mol]; P < 0.001). Occurrence of one or more diabetic ketoacidosis events (11 vs. 4%; P < 0.001) and one or more severe hypoglycemic events (18 vs. 9%; P < 0.001) in the past 3 months was higher among depressed participants. CONCLUSIONS: In the T1D Exchange clinic registry, adults with probable major depression have worse clinical outcomes than those not depressed. Whether identification and treatment of depression improves diabetes outcomes requires study. Depression is common in T1D, and better identification and treatment of this comorbid condition is needed.
Authors: Carrie E Foote; Joyce Mac Kinnon; Chris Robbins; Regina Pessagno; Matthew D Portner Journal: Qual Life Res Date: 2015-06-03 Impact factor: 4.147
Authors: K A Nunley; J F Karp; T J Orchard; T Costacou; H J Aizenstein; J R Jennings; C Rosano Journal: Diabet Med Date: 2019-01-18 Impact factor: 4.359
Authors: Hanna Kampling; Frank Petrak; Erik Farin; Bernd Kulzer; Stephan Herpertz; Oskar Mittag Journal: Diabetologia Date: 2016-10-27 Impact factor: 10.122
Authors: Mary E Lacy; Paola Gilsanz; Chloe Eng; Michal S Beeri; Andrew J Karter; Rachel A Whitmer Journal: Diabetes Care Date: 2019-12-27 Impact factor: 19.112